- Home
- / Universal Ibogaine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Universal Ibogaine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$4.6 M
2024-10-29
Revenue
$2.3 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.1M | 1.0M | 2.3M | ||||
| Gross profit | 1.1M | 1.0M | 2.3M | ||||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | ||||
| Operating expense total | 416.0K | 104.0K | 119.0K | 1.1M | 8.5M | 2.8M | 2.9M |
| Depreciation and amortization | 70.0K | 3.0M | 296.0K | 343.0K | |||
| EBITDA | (416.0K) | (104.0K) | (119.0K) | (1.1M) | (7.5M) | (1.8M) | (577.0K) |
| EBITDA margin, % | -696.7% | -170.4% | -24.8% | ||||
| EBIT | (416.0K) | (104.0K) | (119.0K) | (1.2M) | (10.4M) | (1.9M) | (928.0K) |
| EBIT margin, % | -974.6% | -183.9% | -39.8% | ||||
| Interest income | 8.0K | 6.0K | 1.0K | 32.0K | 5.0K | ||
| Interest expense | 15.0K | 68.0K | 136.0K | 145.0K | |||
| Pre tax profit | (408.0K) | (98.0K) | (118.0K) | (3.9M) | (10.5M) | (2.4M) | (2.1M) |
| Net Income | (408.0K) | (98.0K) | (118.0K) | (3.9M) | (10.5M) | (2.4M) | (2.1M) |